Study protocol for “A Phase 1, Single Center Study to Assess the Safety of MB66, a Combined Anti-HIV (VRC01-N) and Anti-HSV (HSV8-N) Monoclonal Antibody Film for Vaginal Application as Microbicide (MB66-01)”.

Politch, Joseph A.; Cu-Uvin, Susan; Moench, Thomas R.; Tashima, Karen T.; Marathe, Jai G.; Guthrie, Kate M.; Cabral, Howard; Nyhuis, Tara; Brennan, Miles; Zeitlin, Larry; Spiegel, Hans M. L.; Mayer, Kenneth H.; Whaley, Kevin J.; Anderson, Deborah J.

doi:10.1371/journal.pmed.1003495.s015

pmed.1003495.s015.pdf (1.94 MB)

Study protocol for “A Phase 1, Single Center Study to Assess the Safety of MB66, a Combined Anti-HIV (VRC01-N) and Anti-HSV (HSV8-N) Monoclonal Antibody Film for Vaginal Application as Microbicide (MB66-01)”.

journal contribution

posted on 2021-02-03, 18:50 authored by Joseph A. Politch, Susan Cu-Uvin, Thomas R. Moench, Karen T. Tashima, Jai G. Marathe, Kate M. Guthrie, Howard Cabral, Tara Nyhuis, Miles Brennan, Larry Zeitlin, Hans M. L. Spiegel, Kenneth H. Mayer, Kevin J. Whaley, Deborah J. Anderson

(PDF)